Correlation Between Quoin Pharmaceuticals and Nuvectis Pharma
Can any of the company-specific risk be diversified away by investing in both Quoin Pharmaceuticals and Nuvectis Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Quoin Pharmaceuticals and Nuvectis Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Quoin Pharmaceuticals Ltd and Nuvectis Pharma, you can compare the effects of market volatilities on Quoin Pharmaceuticals and Nuvectis Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Quoin Pharmaceuticals with a short position of Nuvectis Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Quoin Pharmaceuticals and Nuvectis Pharma.
Diversification Opportunities for Quoin Pharmaceuticals and Nuvectis Pharma
0.13 | Correlation Coefficient |
Average diversification
The 3 months correlation between Quoin and Nuvectis is 0.13. Overlapping area represents the amount of risk that can be diversified away by holding Quoin Pharmaceuticals Ltd and Nuvectis Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nuvectis Pharma and Quoin Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Quoin Pharmaceuticals Ltd are associated (or correlated) with Nuvectis Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nuvectis Pharma has no effect on the direction of Quoin Pharmaceuticals i.e., Quoin Pharmaceuticals and Nuvectis Pharma go up and down completely randomly.
Pair Corralation between Quoin Pharmaceuticals and Nuvectis Pharma
Given the investment horizon of 90 days Quoin Pharmaceuticals Ltd is expected to under-perform the Nuvectis Pharma. In addition to that, Quoin Pharmaceuticals is 1.4 times more volatile than Nuvectis Pharma. It trades about -0.08 of its total potential returns per unit of risk. Nuvectis Pharma is currently generating about 0.01 per unit of volatility. If you would invest 1,185 in Nuvectis Pharma on November 2, 2024 and sell it today you would lose (511.00) from holding Nuvectis Pharma or give up 43.12% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Quoin Pharmaceuticals Ltd vs. Nuvectis Pharma
Performance |
| Timeline |
| Quoin Pharmaceuticals |
| Nuvectis Pharma |
Quoin Pharmaceuticals and Nuvectis Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Quoin Pharmaceuticals and Nuvectis Pharma
The main advantage of trading using opposite Quoin Pharmaceuticals and Nuvectis Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Quoin Pharmaceuticals position performs unexpectedly, Nuvectis Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nuvectis Pharma will offset losses from the drop in Nuvectis Pharma's long position.| Quoin Pharmaceuticals vs. Revelation Biosciences | Quoin Pharmaceuticals vs. Virax Biolabs Group | Quoin Pharmaceuticals vs. Allarity Therapeutics | Quoin Pharmaceuticals vs. Biodexa Pharmaceticals |
| Nuvectis Pharma vs. Replimune Group | Nuvectis Pharma vs. Lyra Therapeutics | Nuvectis Pharma vs. Kronos Bio | Nuvectis Pharma vs. Gossamer Bio |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Other Complementary Tools
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |